Susquehanna International Group, LLP Passage Bio, Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Passage Bio, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 28,000 shares of PASG stock, worth $239,119. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,000
Previous 50,300
44.33%
Holding current value
$239,119
Previous $17,000
35.29%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PASG
# of Institutions
42Shares Held
35.2MCall Options Held
40.5KPut Options Held
0-
Lynx1 Capital Management LP San Juan, PR9.26MShares$79.1 Million1.1% of portfolio
-
Vestal Point Capital, LP New York, NY6.1MShares$52.1 Million0.13% of portfolio
-
Orbimed Advisors LLC San Diego, CA6.06MShares$51.7 Million0.09% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY2.5MShares$21.3 Million2.97% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.46MShares$21 Million0.01% of portfolio
About Passage BIO, Inc.
- Ticker PASG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,463,200
- Market Cap $465M
- Description
- Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...